![]() |
Volumn 46, Issue 1, 2014, Pages 245-248
|
Disease-related intestinal transplant in adults: Results from a single center
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
DACLIZUMAB;
TACROLIMUS;
THYMOCYTE ANTIBODY;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
LYMPHOCYTE ANTIBODY;
MONOCLONAL ANTIBODY;
ARTICLE;
CANCER STAGING;
CAUSE OF DEATH;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DESMOID TUMOR;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
FEMALE;
FOLLOW UP;
GARDNER SYNDROME;
GRAFT SURVIVAL;
HEALTH CARE POLICY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE GRAFT;
INTESTINE INFARCTION;
INTESTINE PSEUDOOBSTRUCTION;
LIVER FAILURE;
MALE;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
SHORT BOWEL SYNDROME;
STOMACH EMPTYING;
TUMOR RECURRENCE;
TUMOR VOLUME;
ADULT;
AGE;
INTESTINAL DISEASES;
INTESTINAL PSEUDO-OBSTRUCTION;
INTESTINE;
KAPLAN MEIER METHOD;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PROPORTIONAL HAZARDS MODEL;
TOTAL PARENTERAL NUTRITION;
TRANSPLANTATION;
TREATMENT OUTCOME;
ADULT;
AGE FACTORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTILYMPHOCYTE SERUM;
FEMALE;
GARDNER SYNDROME;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINAL DISEASES;
INTESTINAL PSEUDO-OBSTRUCTION;
INTESTINES;
KAPLAN-MEIER ESTIMATE;
MALE;
MIDDLE AGED;
PARENTERAL NUTRITION, TOTAL;
PROPORTIONAL HAZARDS MODELS;
SHORT BOWEL SYNDROME;
TREATMENT OUTCOME;
|
EID: 84893592112
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2013.08.110 Document Type: Article |
Times cited : (13)
|
References (5)
|